TGFB1 and pulmonary arterial hypertension: Genetic variants in other components of the TGF-β/BMPR2 signal pathways, including activin receptor-like kinase 1 (ACVRL1) and endoglin (ENG) have been reported in PAH patients (2, 4–6).